Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.599662
Title: UCP2 in pancreatic beta-cells : a radical way to short circuit glucose sensing?
Author: Green, K.
Awarding Body: University of Cambridge
Current Institution: University of Cambridge
Date of Award: 2005
Availability of Full Text:
Full text unavailable from EThOS.
Please contact the current institution’s library for further details.
Abstract:
Uncoupling proteins (UCPs) catalyse proton transport across the mitochondrial inner membrane, thereby uncoupling oxidative phosphorylation. UCP2 is expressed in several mammalian tissues including pancreatic β-cells. Since UCP2 activity uncouples the processes that link glucose metabolism (oxidation) to insulin secretion (phosphorylation), it is expected to attenuate glucose-stimulated insulin secretion (GSIS). Published studies using UCP2 over-expressing and UCP2 ablated β-cells support this hypothesis. Therefore, identifying regulators of β-cell UCP2 activity may help develop novel ways to treat type II diabetes. Furthermore, β-cells present a valuable system with which to study UCP2 activity in situ. Studies using isolated mitochondria have demonstrated that the superoxide radical and particular reactive alkenals activate UCP2, and that novel, mitochondrially-targeted antioxidants (mito-antioxidants) prevent activation of UCP2 by superoxide. Mito-antioxidants and reactive alkenals are thus useful tools to investigate pancreatic β-cell UCP2 activity in situ. I hypothesised that endogenously produced superoxide activates UCP2 in β-cells to negatively regulate GSIS, and tested this hypothesis by measuring UCP2 activity in isolated β-cell mitochondria and GSIS in intact β-cells. Mito-antioxidants prevented superoxide-activation of UCP2 in isolated β-cell mitochondria but, surprisingly, did not potentiate GSIS. These unexpected findings suggested that either UCP2 was endogenously inactive, or endogenous UCP2 activity is not inhibited by mito-antioxidants. I sought to distinguish between these possibilities using UCP2 overexpressing β-cells, and by investigating isolated mitochondria in which UCP2 appeared to be endogenously active. Certain reactive alkenals both activated UCP2 in β cell mitochondria and attenuated GSIS in intact cells, suggesting that may attenuate insulin secretion physiologically, or provide valuable tools to probe UCP2 activity in cells.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.599662  DOI: Not available
Share: